Telogen Effluvium in Patients Recovering from COVID-19
September 2021
in “
Skin
”
Studysummary In this observational study, nine out of ten patients developed Telogen Effluvium after mild COVID-19 symptoms, with hair shedding starting on average 73 days following infection.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer